Search

Your search keyword '"Wilkinson, Tom"' showing total 309 results

Search Constraints

Start Over You searched for: Author "Wilkinson, Tom" Remove constraint Author: "Wilkinson, Tom" Database Unpaywall Remove constraint Database: Unpaywall
309 results on '"Wilkinson, Tom"'

Search Results

3. Health inequality and COPD

4. Cytokine biomarkers of exacerbations in sputum from Chronic Obstructive Pulmonary Disease patients: a prospective cohort study

6. Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry

8. Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

11. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial

12. 375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease (COPD) Patients With Respiratory Virus Infections

14. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial

17. Collagen Remodelling in COPD: A new paradigm

24. COPD Assessment Test (CAT) Score according to the presence/absence of accelerated lung function decline in young adult smokers with normal FEV1

26. Clinical trials of inhaled interferon beta-1a (SNG001) in COVID-19 patients in the home and hospital

27. Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study

30. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

32. A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

33. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study

34. Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study

35. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease

38. Antiviral Responses of Tissue-resident CD49a+ Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease

39. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial

40. Nebulised interferon beta-1a (SNG001) in hospitalised COVID-19: SPRINTER Phase III Study

43. Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD

44. LB1533. Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial

47. Simultaneous Optimization ofMP2RAGE T 1‐weighted ( UNI ) and FLuid And White matter Suppression ( FLAWS ) brain images at 7T using Extended Phase Graph ( EPG ) Simulations

48. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study.

50. Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon

Catalog

Books, media, physical & digital resources